While the top- and bottom-line numbers for Abbott (ABT) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Abbott (NYSE: ABT) reported its full-year and fourth-quarter results for 2022 on Wednesday. Abbott's bad news definitely jumped out. While Abbott's sales fell 12% on a reported basis, the year-over-year decline was only 6.1% excluding the impact of foreign exchange.
Double beats for its latest quarter couldn't keep the bears away from the company's shares on Hump Day.